Mounjaro 3 month starter pack: what does the first quarter of treatment actually look like?

What does a 3 month Mounjaro starter pack actually contain?

Strictly speaking, Mounjaro does not come in a pre-assembled "starter pack" the way a gift set might. What the phrase describes is the opening chapter of a tirzepatide course: typically three consecutive pens covering the 2.5 mg, 5 mg, and sometimes 7.5 mg steps, each pen containing four weekly doses. Whether you progress from 2.5 mg to 5 mg to 7.5 mg within those 12 weeks, or stay longer at an earlier dose, is a clinical decision your prescriber makes based on how well you are tolerating the treatment.

A question our prescribers hear most weeks is whether it is possible to jump straight to a higher dose to speed things up. The short answer is no, and for good reason. The graduated schedule exists because GI side effects are substantially more manageable when the dose rises slowly. Rushing it rarely saves time and often costs comfort. You can read more about how Mounjaro works as a whole if you want the fuller picture on mechanism and titration.

Because Mounjaro is a prescription-only medicine regulated by the MHRA, any legitimate supply requires a valid prescription from a registered prescriber who has assessed your suitability. The process of obtaining Mounjaro through a regulated online pharmacy begins with that consultation, not with selecting a pack size.

Does the dose schedule change what you should expect in weeks one to twelve?

Yes, and it is worth being concrete about this. Week one to four at 2.5 mg is largely about adjustment. Some people notice very little; others feel nausea, loose stools, or low appetite quite early. These effects are typically most noticeable in the first few days after each injection and settle as your body adapts. They are not a signal that the medicine is not working, they are a signal that it is doing something.

Moving to 5 mg at week five often brings a more noticeable appetite shift for people who felt little at 2.5 mg. The same pattern can repeat when 7.5 mg starts, if your prescriber moves you there. If you are wondering what type of drug Mounjaro is and how it fits into the wider landscape of weight loss medicines, that context can help make sense of why the dose escalation is structured the way it is. The clinical evidence for tirzepatide comes largely from the SURMOUNT trial programme, which followed participants across 72 weeks, the first three months represent the build-up phase, not the full picture. Most meaningful weight change accumulates over several months of treatment at a maintained dose.

The NHS's patient-level guidance on tirzepatide covers what to expect at each stage and is worth reading alongside any information you receive from your prescriber. NHS guidance on tirzepatide sets out common side effects and how to manage them clearly, without jargon.

Who is the starter phase of Mounjaro appropriate for?

The licensed eligibility for Mounjaro in the UK, per the medicine's summary of product characteristics, covers adults with a BMI of 30 or above, or a BMI of 27 or above alongside at least one weight-related condition such as high blood pressure, type 2 diabetes, high cholesterol, or obstructive sleep apnoea. Lower BMI thresholds apply for some ethnic backgrounds under UK clinical guidance. BMI alone does not confirm suitability; the prescriber assesses your full health picture.

People who are pregnant, breastfeeding, or actively trying to conceive are not suitable for tirzepatide. Those under 18 are also outside the licensed indication. Certain conditions, including a personal or family history of medullary thyroid cancer or a history of pancreatitis, require careful prescriber discussion before any decision is made.

If you have previously been on Mounjaro through another provider and want to continue or transfer to a clinical service that reviews each order individually, you can explore what the starter pack process involves at a regulated pharmacy. Transfer patients at nume are asked for evidence of their current treatment and dose before any prescription is issued.

What does cost look like across the first three months?

Private Mounjaro pricing in the UK is quoted per pen (one pen equals one month of treatment). Since Eli Lilly raised UK list prices from September 2025, market rates for the higher doses have risen substantially, with some providers charging upwards of £300 per pen at the top of the schedule. The 2.5 mg and 5 mg starter doses are generally priced lower than maintenance doses, though this varies by provider.

It is worth being clear about what legitimate pricing includes: the consultation, the prescription, dispensing from a GPhC-registered pharmacy, and delivery. Some advertised prices exclude one or more of these. Our Mounjaro starter bundle brings together the consultation, prescription, and first pens into a single transparent price, so you can see exactly what you are paying for before you commit. There are no subscriptions, no auto-renewals, and no hidden prescription fees.

NICE's appraisal of tirzepatide (TA1026) confirms its recommendation for NHS use under specific criteria, which helps explain why private routes exist and why demand for the medicine has grown. NICE TA1026 is publicly available if you want to read the full eligibility framework that governs NHS access.